Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02339922
Title Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington

Waldenstroem's macroglobulinemia

follicular lymphoma

mantle cell lymphoma

marginal zone B-cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma


Ixazomib + Rituximab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.